Expanded spectrum of varicella disease and the need for vaccination in India
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 22, 2024 Category: Allergy & Immunology Authors: Padma SrikanthIlakkiya ArumugamSeetha N. JeganathanRithvik RameshLakshmi Narasimhan RanganathanShanthi Vijayaraghavana Department of Microbiology, Sri Ramachandra Medical College and Research Institute (SRIHER, DU), Chennai, Indiab Department of Neurology Source Type: research

COVID-19 vaccines: Immune correlates and clinical outcomes
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 22, 2024 Category: Allergy & Immunology Authors: Shant H. MahrokhianLisa H. TostanoskiSamuel J. VidalDan H. Baroucha Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAb Department of Medicine, Tufts University School of Medicine, Bosto Source Type: research

Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 22, 2024 Category: Allergy & Immunology Authors: Guoxi CaiShiwen LiuYixiao LuYumika TakakiFumiaki MatsumotoAkira YoshikawaToshitsugu TaguriJianfen XieKazuhiko ArimaSatoshi MizukamiJiwen WuTaro YamamotoMaiko HasegawaNguyen Tien HuyMasaya SaitoShouhei TakeuchiKouichi MoritaKiyoshi AoyagiFei Hea Public Hea Source Type: research

Intranasal delivery of Salmonella OMVs decorated with Chlamydia trachomatis antigens induces specific local and systemic immune responses
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 22, 2024 Category: Allergy & Immunology Authors: Dung T. HuynhEmanuele NolfiLobna MedfaiPeter van UlsenWouter S. P. JongAlice J. A. M. SijtsJoen Luirinka R & D department, Abera Bioscience AB, Uppsala, Swedenb Group of Molecular Microbiology, Amsterdam Institute for Life and Environment (A-LIFE), Vrije Source Type: research

The seroepidemiology of immunoglobulin G antibodies against pertussis toxin and filamentous hemagglutinin in the east of China during the COVID-19 pandemic
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 22, 2024 Category: Allergy & Immunology Authors: Xiang SunTingting ZhangJinning SunJuan ZhouQiang ChenChengmei JiaYan XuYun WuZhiguo WangWen Wanga Department of Expanded Program on Immunization, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Chinab Medical Record Office, Children Source Type: research

Opportunities for HPV vaccine education in school-based immunization programs in British Columbia, Canada: A qualitative study
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 22, 2024 Category: Allergy & Immunology Authors: Isabella BrohmanGabriel BlankHana MitchellEve Dub éJulie A. Bettingera Vaccine Evaluation Center, BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, BC, Canadab Faculty of Medicine, School of Population and Public Hea Source Type: research

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 21, 2024 Category: Allergy & Immunology Authors: Prasad S. KulkarniChandrasekaran PadmapriyadarsiniJohan VekemansAshish BavdekarMadhu GuptaPraveen KulkarniB.S. GargNithya J. GogtayMuralidhar TambeSanjay LalwaniKiranjit SinghRenuka MunshiSushant MeshramT.S. SelvavinayagamKrishna PandeyDevi Madhavi Bhimar Source Type: research

No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 21, 2024 Category: Allergy & Immunology Authors: Abdi NaficyAdrienne KuxhausenHarry SeifertAndrew HastieBrett LeavJacqueline MillerKate AnteyiAgnes Mwakingwe-Omaria GSK, Rockville, MD, USAb Moderna, Inc, Cambridge, MA, USA Source Type: research

A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 21, 2024 Category: Allergy & Immunology Authors: Shaomin ChenZhifang YingYan LiuYuan LiYebin YuMeilian HuangZhuhang HuangZhiqiang OuYuyi LiaoYong ZhangGuixiu LiuWeiwei ZhaoRong FuQiong ShouMinghuan ZhengXueyan LiaoYingmei TuJon StekJonathan HartzelChanggui LiJikai Zhanga Biological Products Surveillance Source Type: research

Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 21, 2024 Category: Allergy & Immunology Authors: Nuttapat PisuttinusartKaewta RattanapisitChanya SrisaowakarnArunee ThitithanyanontRichard StrasserBalamurugan ShanmugarajWaranyoo Phoolcharoena Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn Univer Source Type: research

A systematic review of measures of healthcare workers ’ vaccine confidence
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 20, 2024 Category: Allergy & Immunology Authors: Kofoworola O. AkinsolaAyobami A. BakareElisa GobboCarina KingClaudia HansonAdegoke FaladeSibylle Herzig van Weesa Department of Pediatrics, University College Hospital, Ibadan, Nigeriab Department of Community Medicine, University College Hospital, Ibadan Source Type: research

Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 20, 2024 Category: Allergy & Immunology Authors: Yordanos Sisay AsgedomTsegaye Melaku KebedeBeminate Lemma SeifuKusse Urmale MareZufan Alamrie AsmareHiwot Altaye AsebeBizunesh Fantahun KaseAbdu Hailu ShibeshiTsion Mulat TebejeKebede Gemeda SaboBezawit Melak FenteAfework Alemu LombeboMengistu Meskele Koy Source Type: research

Politics and confidence toward the COVID-19 vaccination: Points to be considered
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 19, 2024 Category: Allergy & Immunology Authors: Somsri WiwanitkitViroj Wiwanitkita Private Academic and Editorial Consultant, Bangkok, Thailandb University Centre for Research & Development Department of Pharmaceutical Sciences, Chandigarh University, Mohali, India Source Type: research

Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 19, 2024 Category: Allergy & Immunology Authors: Sydney GeorgeJessica ReganAmnah AwanMeaghan O ’ConnorApril FosterKimberly RaymondIris GorfinkelShelly A. McNeila GSK, Mississauga, ON, Canadab QualityMetric Inc., Johnston, RI, USAc PrimeHealth Clinical Research, Toronto, ON, Canadad Canadian Center for Source Type: research

Bidirectional crosstalk between the epithelial-mesenchymal transition and immunotherapy: A bibliometric study
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 19, 2024 Category: Allergy & Immunology Authors: Wei DuZemin TangAshuai DuQinglong YangRong Xua Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University (The First People ’s Hospital of Changde City), Changde, Hunan, Chinab Department of Infectious Diseases, Guiz Source Type: research